- ≥99% by HPLC per component; lot-matched COA
- Lot-matched certificate of analysis
- Ships next business day, tracked
BPC-157 + TB-500 + KPV
Co-formulated 30 mg research vial of BPC-157, TB-500 and KPV at 10 mg each
- FormLyophilized powder, sealed glass vial
- Research areasGastrointestinal mucosa, inflammatory signalling, connective-tissue repair models
Supplied for laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
Overview
This blend places three peptides at equal weight — BPC-157, TB-500 and KPV, 10 mg each — into a single 30 mg lyophilized vial. Unlike the copper-heavy GLOW and KLOW formulations, the even 10/10/10 split keeps the three components on comparable footing, which suits study designs where no single peptide is meant to dominate the preparation.
The combination is common in gastrointestinal and inflammatory research contexts, where the mucosal orientation of BPC-157 and the NF-κB-related interest in KPV overlap. MyPeptide supplies the vial as a white lyophilized powder assayed to ≥99% purity per component by HPLC, released against a lot-matched certificate of analysis, and sold strictly for laboratory research use.
Specifications
Supply & purity
- Form
- Lyophilized powder, sealed glass vial
- Purity
- ≥99% by HPLC per component; lot-matched COA
- Solubility
- Bacteriostatic water or sterile water
Handling & storage
- Storage (lyophilized)
- −20 °C, protected from light and moisture
- Storage (reconstituted)
- 2–8 °C, used within the study window
Additional detail
- Product type
- Three-peptide research blend, single vial
- Components
- BPC-157, TB-500 (thymosin beta-4 fragment), KPV
- Total peptide content
- 30 mg per vial (10 mg each)
- BPC-157
- CAS 137525-51-0 · C62H98N16O22 · 1419.55 g/mol
- TB-500
- CAS 885340-08-9 · C38H68N10O14 · 889.02 g/mol
- KPV
- CAS 67727-97-3 · C16H30N4O4 · 342.43 g/mol
- Appearance
- White to off-white powder; clear colourless solution when reconstituted
- Research areas
- Gastrointestinal mucosa, inflammatory signalling, connective-tissue repair models
Questions about BPC-157 + TB-500 + KPV
How does this differ from a BPC-157 and TB-500 blend?
The addition of KPV is the difference. Two-peptide Wolverine-style blends cover the repair and cell-migration literature; adding the alpha-MSH-derived tripeptide brings an inflammatory-signalling component that laboratories working on mucosal or colitis models typically want in the same vial.
What is the ratio in this vial?
Equal parts by mass — 10 mg of BPC-157, 10 mg of TB-500 and 10 mg of KPV, for 30 mg total. Because the three molecules differ substantially in molecular weight, the molar ratio is not 1:1:1; KPV contributes the most molecules per milligram.
Is each component tested separately?
Yes. The lot-matched certificate of analysis reports identity and purity for BPC-157, TB-500 and KPV individually by HPLC rather than giving a single combined figure. Request the current lot COA if you want to review it before ordering.
Should the reconstituted solution be coloured?
No. Unlike GHK-Cu-containing blends, this formulation has no copper complex, so a properly reconstituted vial gives a clear colourless solution. Any tint, cloudiness or visible particulate is a reason to stop and set the vial aside.
Can this be used on people or animals?
No. This is a research chemical sold for in-vitro and laboratory use by qualified researchers only. It is not a drug, supplement or veterinary product, it has not been evaluated for administration to any living subject, and MyPeptide supplies no dosing or usage instructions.
Related
